Tachykinins and the potential causal factors for post-COVID-19 condition
Author | Janket, Sok-Ja |
Author | Fraser, Douglas D |
Author | Baird, Alison E |
Author | Tamimi, Faleh |
Author | Sohaei, Dorsa |
Author | Conte, Harry A |
Author | Prassas, Ioannis |
Author | Diamandis, Eleftherios P |
Available date | 2023-12-28T05:14:42Z |
Publication Date | 2023 |
Publication Name | The Lancet Microbe |
Resource | Scopus |
ISSN | 26665247 |
Abstract | The most prevalent symptoms of post-COVID-19 condition are pulmonary dysfunction, fatigue and muscle weakness, anxiety, anosmia, dysgeusia, headaches, difficulty in concentrating, sexual dysfunction, and digestive disturbances. Hence, neurological dysfunction and autonomic impairments predominate in post-COVID-19 condition. Tachykinins including the most studied substance P are neuropeptides expressed throughout the nervous and immune systems, and contribute to many physiopathological processes in the nervous, immune, gastrointestinal, respiratory, urogenital, and dermal systems and participate in inflammation, nociception, and cell proliferation. Substance P is a key molecule in neuroimmune crosstalk; immune cells near the peripheral nerve endings can send signals to the brain with cytokines, which highlights the important role of tachykinins in neuroimmune communication. We reviewed the evidence that relates the symptoms of post-COVID-19 condition to the functions of tachykinins and propose a putative pathogenic mechanism. The antagonism of tachykinins receptors can be a potential treatment target. |
Language | en |
Publisher | Elsevier |
Subject | Tachykinins COVID-19 pulmonary dysfunction |
Type | Article Review |
Pagination | e642-e650 |
Issue Number | 8 |
Volume Number | 4 |
Check access options
Files in this item
This item appears in the following Collection(s)
-
COVID-19 Research [811 items ]
-
Dental Medicine Research [285 items ]